Preclinical Data Shows Ability of Antibody Combo to Neutralize Omicron Variants

March 23, 2022 by Alexa Hornbeck
Preclinical Data Shows Ability of Antibody Combo to Neutralize Omicron Variants

This week, researchers from Washington University School of Medicine released preclinical data that shows a long-acting antibody combination called Evusheld can neutralize activity against omicron variants of the COVID-19 virus, including BA.2.

To conduct the study, researchers used in vivo data generated using mice infected with omicron BA.1 and BA.2 to demonstrate that Evusheld could significantly reduce the viral burden and limit inflammation in the lungs for both subvariants. 

The data shows that Evusheld’s ability to reduce omicron’s viral load may also decrease the likelihood of severe infection or death, as well as long-COVID symptoms. 

Evusheld was developed by AstraZeneca with support from the U.S. government and funds from the Department of Health and Human Services. 

The treatment received emergency use authorization in the U.S. in December 2021 for preventing COVID-19 in people who are moderately to severely immunocompromised due to a medical condition or immunosuppressive medication.

The findings about Evusheld come after previous studies showed the omicron variant can escape certain antibody combinations.

A study published in Nature Medicine on Jan. 19 finds that several antibody combinations in clinical use by Celltrion, Regeneron and Eli Lilly had completely lost the ability to neutralize the omicron variant in cell culture. 

Alexa can be reached at [email protected]

A+
a-

In The News

Health

Voting

Health

Biden Announcing New Rule to Protect Consumers Who Purchase Short-Term Health Insurance Plans

President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A... Read More

President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president's administration will limit these plans to just three months. And the plans can only be renewed for a maximum... Read More

March 27, 2024
by Dan McCue
One-Time Treatment Could Revitalize Immune Systems in the Elderly

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

March 27, 2024
by Dan McCue
Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

Five Takeaways From the Abortion Pill Case Before US Supreme Court

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

March 26, 2024
by Tom Ramstack
Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

News From The Well
scroll top